You are here

Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

Last updated on December 6, 2018

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Mecidiyekoy, Istanbul, 34394 Turkey
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Dyslipidemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients diagnosed with dyslipidemia and taking or planning to take statin treatment.

- Patients living in the same city of the study center. o Patients aged 18 years and
over.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with severe systemic disease

- Patients with alcohol and drug addiction and/or mental disease

- Patients nursing or pregnant, or planning to get pregnant during the study

NCT00673660
Pfizer
Completed
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Primary Hyperlipidemia or Mixed Dyslipidemia
NCT02947334
All Genders
18+
Years
Beijing, Beijing
Hyperlipidemia, Dyslipidemia, Hypercholesterolemia
NCT00267280
All Genders
18+
Years
Multiple Sites
Hyperlipidemia, Dyslipidemia, Hypercholesterolemia
NCT00267254
All Genders
18+
Years
Multiple Sites
Coronary Arteriosclerosis, Type 2 Diabetes Mellitus, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular Disease
NCT00442325
All Genders
18+
Years
Multiple Sites
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Assessment Of Statin Treatment Compliance In Dyslipidemia Patients: An Observational Study
The purpose of the study is to show the compliance rates of the patients to statin treatment and the reasons of non-compliance.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   None Retained
Description:
No biospecimen is retained
Non-Probability Sample
Patients diagnosed with dyslipidemia and taking or planning to take statin treatment. Patients living in the same city of the study center. Patients aged 18 years old and over.
Dyslipidemia
Behavioral: Patient Compliance
Compliance of patients to statin treatment and reasons of compliance or non compliance will be obtained by Patient Reported Outcomes (PROs) every 3 months.
Statins
Patients with dyslipidemia who are taking or planning to take a statin treatment (Atorvastatin, Fluvastatin, Prevastatin, Rosuvastatin, Simvastatin or generics).
Intervention: Behavioral: Patient Compliance
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
375
October 2009
October 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients diagnosed with dyslipidemia and taking or planning to take statin treatment.
  • Patients living in the same city of the study center. o Patients aged 18 years and over.

Exclusion Criteria:

  • Patients with severe systemic disease
  • Patients with alcohol and drug addiction and/or mental disease
  • Patients nursing or pregnant, or planning to get pregnant during the study
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Turkey
 
 
NCT00673660
A2581156
No
Not Provided
Not Provided
Director, Clinical Trial Disclosure Group, Pfizer, Inc.
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
December 2009

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now